Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-012303
Filing Date
2018-01-17
Accepted
2018-01-17 17:17:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d414494d424b5.htm 424B5 261252
2 GRAPHIC g414494g0116030209305.jpg GRAPHIC 5282
  Complete submission text file 0001193125-18-012303.txt   269980
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-214315 | Film No.: 18532220
SIC: 2834 Pharmaceutical Preparations